America Handing MRNA Lead: Investors Reassess Biotech
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Identify and prune unused or duplicative subscriptions with a simple audit. This intro covers tracking, prioritizing, and scaling back renewals.
19,895 articlesA political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
With the CLARITY Act stalled in the Senate, XRP traders await a potential reset. A clearance could alter liquidity an...
In a world of market swings, a simple, broad-based approach can anchor your portfolio. The Vanguard Total Stock Marke...
Bitcoin dropped below the $67,000 level as U.S. Treasury yields climbed toward yearly highs, igniting a risk-off shak...
The latest CBO outlook warns the OASI trust fund could run dry by 2032 if reforms stall, signaling potential changes ...
Disney reports stronger-than-expected Q2 2026 results, lifting the stock 8% in early trading as streaming and parks r...
Dine Brands (DIN) 2026 presents a pivotal earnings outlook with evolving margins, franchise dynamics, and a path to g...
Celanese (CE) stands at an inflection point as 2026 begins. This article breaks down the potential drivers behind cel...
Ethereum sits in a tight range while on-chain tokenized Treasuries on the network surpass $8 billion, marking a major...
In Q1 2026, new homes held prices steady while resale values declined, signaling a pricing strategy where discounts r...
In today’s stock market today, Nokia priced lower by about 6% as traders weigh AI hype against fundamentals. This pie...
IREN leaps on a landmark NVIDIA AI Cloud contract and a parallel equity option, signaling a strategic pivot from cryp...